Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
108.01
-4.38 (-3.90%)
Apr 4, 2025, 3:41 PM EDT - Market open
Gilead Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 480 | 5,665 | 4,592 | 6,225 | 123 | Upgrade
|
| Depreciation & Amortization | 2,767 | 2,693 | 2,103 | 2,050 | 1,480 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8,843 | 1,205 | 3,644 | 939 | 5,968 | Upgrade
|
| Loss (Gain) From Sale of Investments | 274 | 167 | 657 | 610 | 1,662 | Upgrade
|
| Stock-Based Compensation | 835 | 766 | 637 | 635 | 643 | Upgrade
|
| Other Operating Activities | -1,491 | -187 | -798 | 436 | -70 | Upgrade
|
| Change in Accounts Receivable | 139 | 157 | -406 | 313 | -1,171 | Upgrade
|
| Change in Inventory | -426 | -842 | -310 | 11 | -195 | Upgrade
|
| Change in Accounts Payable | 290 | -347 | 226 | -118 | 80 | Upgrade
|
| Change in Income Taxes | -732 | -1,768 | -364 | -361 | -778 | Upgrade
|
| Change in Other Net Operating Assets | -151 | 497 | -909 | 644 | 426 | Upgrade
|
| Operating Cash Flow | 10,828 | 8,006 | 9,072 | 11,384 | 8,168 | Upgrade
|
| Operating Cash Flow Growth | 35.25% | -11.75% | -20.31% | 39.37% | -10.67% | Upgrade
|
| Capital Expenditures | -523 | -585 | -728 | -579 | -650 | Upgrade
|
| Cash Acquisitions | -4,840 | -1,152 | -1,797 | -1,584 | -25,920 | Upgrade
|
| Investment in Securities | 1,856 | -528 | 60 | -987 | 11,948 | Upgrade
|
| Other Investing Activities | 58 | - | -1 | 19 | 7 | Upgrade
|
| Investing Cash Flow | -3,449 | -2,265 | -2,466 | -3,131 | -14,615 | Upgrade
|
| Long-Term Debt Issued | 3,464 | 1,980 | - | - | 8,184 | Upgrade
|
| Long-Term Debt Repaid | -1,970 | -2,250 | -1,500 | -4,750 | -2,500 | Upgrade
|
| Net Debt Issued (Repaid) | 1,494 | -270 | -1,500 | -4,750 | 5,684 | Upgrade
|
| Issuance of Common Stock | 422 | 232 | 309 | 169 | 256 | Upgrade
|
| Repurchase of Common Stock | -1,150 | -1,000 | -1,396 | -546 | -1,583 | Upgrade
|
| Common Dividends Paid | -3,918 | -3,809 | -3,709 | -3,605 | -3,449 | Upgrade
|
| Other Financing Activities | -281 | -278 | -173 | -145 | -138 | Upgrade
|
| Financing Cash Flow | -3,433 | -5,125 | -6,469 | -8,877 | 770 | Upgrade
|
| Foreign Exchange Rate Adjustments | -40 | 57 | -63 | -35 | 43 | Upgrade
|
| Net Cash Flow | 3,906 | 673 | 74 | -659 | -5,634 | Upgrade
|
| Free Cash Flow | 10,305 | 7,421 | 8,344 | 10,805 | 7,518 | Upgrade
|
| Free Cash Flow Growth | 38.86% | -11.06% | -22.78% | 43.72% | -9.63% | Upgrade
|
| Free Cash Flow Margin | 35.84% | 27.37% | 30.59% | 39.57% | 30.45% | Upgrade
|
| Free Cash Flow Per Share | 8.21 | 5.90 | 6.61 | 8.56 | 5.95 | Upgrade
|
| Cash Interest Paid | 951 | 891 | 907 | 979 | 951 | Upgrade
|
| Cash Income Tax Paid | 2,779 | 3,990 | 3,136 | 2,509 | 2,639 | Upgrade
|
| Levered Free Cash Flow | 10,131 | 8,465 | 6,935 | 10,203 | 7,965 | Upgrade
|
| Unlevered Free Cash Flow | 10,741 | 9,055 | 7,520 | 10,829 | 8,580 | Upgrade
|
| Change in Net Working Capital | -849 | -354 | 1,358 | -1,265 | 175 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.